Benign prostatic hyperplasia surgery: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Benign prostatic hyperplasia}} {{SCC}} ==Overview== ==Surgery== If medical treatment fails, transurethral resection of prostate (TURP) surgery may need to be ...")
 
No edit summary
Line 2: Line 2:
{{Benign prostatic hyperplasia}}
{{Benign prostatic hyperplasia}}
{{SCC}}
{{SCC}}
==Overview==
==Surgery==
==Surgery==
If medical treatment fails, [[transurethral resection of prostate]] (TURP) surgery may need to be performed. This involves removing (part of) the prostate through the [[urethra]].  There are also a number of new methods for reducing the size of an enlarged prostate, some of which have not been around long enough to fully establish their safety or side effects.  These include various methods to destroy or remove part of the excess tissue while trying to avoid damaging what's left.  Transurethral electrovaporization of the prostate (TVP), laser TURP, visual laser ablation (VLAP), TransUrethral Microwave ThermoTherapy (TUMT), [[Transurethral needle ablation of the prostate|TransUrethral Needle Ablation]] (TUNA), ethanol injection, and others are studied as alternatives.
If medical treatment fails, [[transurethral resection of prostate]] (TURP) surgery may need to be performed. This involves removing (part of) the prostate through the [[urethra]].  There are also a number of new methods for reducing the size of an enlarged prostate, some of which have not been around long enough to fully establish their safety or side effects.  These include various methods to destroy or remove part of the excess tissue while trying to avoid damaging what's left.  Transurethral electrovaporization of the prostate (TVP), laser TURP, visual laser ablation (VLAP), TransUrethral Microwave ThermoTherapy (TUMT), [[Transurethral needle ablation of the prostate|TransUrethral Needle Ablation]] (TUNA), ethanol injection, and others are studied as alternatives.
Line 14: Line 12:


==References==
==References==
{{Reflist|2}}


{{Reflist|2}}


[[Category:Andrology]]
[[Category:Andrology]]
[[Category:Urology]]
[[Category:Urology]]
[[Category:Surgery]]
[[Category:Primary care]]
[[Category:Disease]]
{{WH}}
{{WS}}

Revision as of 20:15, 26 March 2013

Benign prostatic hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Benign Prostatic Hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Benign prostatic hyperplasia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Benign prostatic hyperplasia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Benign prostatic hyperplasia surgery

CDC on Benign prostatic hyperplasia surgery

Benign prostatic hyperplasia surgery in the news

Blogs on Benign prostatic hyperplasia surgery

Directions to Hospitals Treating Benign prostatic hyperplasia

Risk calculators and risk factors for Benign prostatic hyperplasia surgery

Steven C. Campbell, M.D., Ph.D.

Surgery

If medical treatment fails, transurethral resection of prostate (TURP) surgery may need to be performed. This involves removing (part of) the prostate through the urethra. There are also a number of new methods for reducing the size of an enlarged prostate, some of which have not been around long enough to fully establish their safety or side effects. These include various methods to destroy or remove part of the excess tissue while trying to avoid damaging what's left. Transurethral electrovaporization of the prostate (TVP), laser TURP, visual laser ablation (VLAP), TransUrethral Microwave ThermoTherapy (TUMT), TransUrethral Needle Ablation (TUNA), ethanol injection, and others are studied as alternatives.

Newer techniques involving lasers in urology have emerged in the last 5-10 years. Starting with the VLAP technique involving the Nd:YAG laser with contact on the prostatic tissue. A similar technology called Photoselective Vaporization of the Prostate (PVP) with the GreenLight (KTP) laser have emerged very recently. This procedure involves a high powered 80 Watt KTP laser with a 550 micrometre laser fiber inserted into the prostate. This fiber has an internal reflection with a 70 degree deflecting angle. It is used to vaporize the tissue to the prostatic capsule. KTP lasers target haemoglobin as the chromophore and have typically have a penetration depth of 2.0mm (four times deeper than holmium).

Another procedure termed Holmium Laser Ablation of the Prostate (HoLAP) has also been gaining acceptance around the world. Like KTP the delivery device for HoLAP procedures is a 550um disposable side-firing fiber that directs the beam from a high powered 100 Watt laser at a 70degree from the fiber axis. The holmium wavelength is 2,140nm, which falls within the infrared portion of the spectrum and is invisible to the naked eye. Where KTP relies on haemoglobin as a chromophore, water within the target tissue is the chromophore for Holmium lasers. The pentration depth of Holmium lasers is <0.5mm avoiding complications associated with tissue necrosis often found with the deeper penetration and lower peak powers of KTP.

Both wavelengths, KTP and Holmium, ablate approximately one to two grams of tissue per minute.

References

Template:WH Template:WS